Berry to Showcase Patient-Centric Drug Delivery Solutions at Pharmapack 2024

Name: Berry Global, Inc.
Address: 101 Oakley Street, Evansville, Indiana, 47710
Telephone: +1 (877) 662-3779
Price range: £000 - £0000000

January 23, 2024

Featured products will support improved dosing, administration, and medication adherence

Berry Global Healthcare, an expert in creating patient-centred package design, will showcase its latest range of standard and bespoke pharmaceutical packaging solutions at Pharmapack 2024. At the event, customers will have the opportunity to explore a variety of products designed to help patients dose better and hear from Berry’s experts about its contract development and manufacturing organization (CDMO) service for fast-to-market healthcare devices and packaging.

At Berry’s stand, attendees can have an up-close look at products designed as part of the company’s ‘Dose Better’ initiative to deliver patient-centred packaging and drug delivery devices that enhance dosing, administration, and medication adherence. Included among these products will be Berry’s Pneumohaler, a lightweight, breath-actuated, multidose inhaler dose counter for the control and treatment of Asthma and Chronic Obstructive Pulmonary Disease (COPD); Risdrop, a unique patented ophthalmic nozzle for safe, consistent, and reliable drug delivery to the exact location in the eye; and the Berry Digi-Cap™ child-resistant closure that integrates innovative digital technology to improve medication adherence.

The exhibition will also see the launch of the BerryHaler, an all-plastic, dual chamber, dry powder inhaler (DPI) designed to deliver combination drugs and separately store two medications for subsequent simultaneous inhalation.

In addition, the Berry stand will highlight the company’s fully integrated CDMO service to provide customers with complete end-to-end solutions, from product conceptualization through manufacturing to final packaging. This service helps ensure speed to market of customised drug delivery products that meet specific customer requirements and evolving healthcare needs.

With sustainability as another key requirement for many pharmaceutical companies’ new packaging and medical device specifications, Berry will present a sustainability workshop as part of Pharmapack’s events programme. Achieving More Together: How Collaborative Action Drives Innovation and Circularity in Healthcare Packaging, which takes place on the first day of the exhibition (11.15am, Rooms 725 & 726), will focus on how companies can achieve both environmental sustainability and patient wellbeing through innovative drug delivery solutions, with practical strategies for creating sustainable and effective medical and pharmaceutical packaging.

“Pharmapack provides the perfect opportunity for pharmaceutical professionals to learn about the latest developments in packaging and drug delivery solutions,” said Alan Quemeneur, VP Sales, Business Development and R&D, Berry Global Healthcare.
“Our Dose Better initiative is focused on working with our consumer and pharmaceutical healthcare customers to improve adherence, administration, and safety. Berry’s Global Healthcare unit is relentlessly committed to creating innovative solutions and services that better the patient experience. We look forward to sharing our latest innovations with visitors.”

Berry will be located at stand A66. Visitors can schedule a meeting ahead of the exhibition by emailing healthcare@berryglobal.com.

News & Insights

Berry Global Invests to Increase Production Capacity for Healthcare Products

Berry Global Group, Inc., a leader in the design, development, and production of patient-centred healthcare solutions, has invested in additional assets and manufacturing capabilities to increase its healthcare production capacity by up to 30% across three of its European sites.
Following the opening of its manufacturing facility and healthcare center of excellence in Bangalore, India, these latest investments underline Berry’s commitment to delivering high-quality packaging and drug delivery devices that enhance the patient experience through improved medicine administration and adherence.

Berry’s Dual Chamber Inhaler Enables Access to Combination Drugs

Berry Global, a leader in the design, development, and production of patient-centred healthcare solutions, recently launched the BerryHaler, a dual chamber, dry powder inhaler (DPI) with a dose counter designed to provide better patient access to and support the effective delivery of combination drugs.

Berry Acquires F&S Tool Inc., Expands Full Plastic Packaging Lifecycle Solutions for Customers

Berry Global Group, Inc. (NYSE: BERY) announces its acquisition of F&S Tool, a specialized provider of high output, high-efficiency hot runner injection and high-volume compression molding applications. This acquisition will further enhance Berry’s global tooling capability as well as bring proprietary technologies in the closures and bottles space, specifically targeting high-end growth markets.

Berry Global Again Recognized by CDP for Climate Leadership and Supplier Engagement

Global packaging leader Berry Global Group, Inc. has again earned prestigious Climate Change and Supplier Engagement “A-” ratings from global sustainability disclosure non-profit, CDP. The company's prioritization of climate action and supply chain transparency – above both global and North American regional averages – places it among the top 18% and 15%, respectively, of plastic product manufacturers to reach the “Leadership” band. Calculated based on environmental disclosure and performance, CDP ratings underscore Berry’s commitment to working with its suppliers to achieve net-zero emissions across its global operations and value chain by 2050.

Let us serve you

If you'd prefer to call us: +1 (877) 662-3779
Contact information for our global facilities can be found via our locations page.

Tell us more about how we can serve you so we can connect you with the right person.

*Required for details, read our Privacy and Cookies Policy